Thermo Fisher Scientific (TMO) said Tuesday that it signed a 10-year virtual power purchase agreement with X-ELIO, designed to increase access to renewable electricity across pharmaceutical and healthcare supply chains.
The medical device maker said the Lorca solar project is set to begein operations early next year and will involve three partners from the pharmaceutical and healthcare sectors.
The company said its 73 megawatt share of the project will generate 150,000 megawatt-hours of renewable electricity per year, enough to power 40,500 European homes for a year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。